Navegar

Colección

Datos Estadísticas

Lista de

tumor immunity
19
"Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk" (2018) Orozco, C.A.;Martinez-Bosch, N.;Guerrero, P.E. (...)Navarro, P. Proceedings of the National Academy of Sciences of the United States of America. 115(16):E3769-E3778
"Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk" (2018) Orozco, C.A.;Martinez-Bosch, N.;Guerrero, P.E. (...)Navarro, P. Proceedings of the National Academy of Sciences of the United States of America. 115(16):E3769-E3778
"Galectin-1: A jack-of-all-trades in the resolution of acute and chronic inflammation" (2017) Sundblad, V.; Morosi, L.G.; Geffner, J.R.; Rabinovich, G.A. Journal of Immunology. 199(11):3721-3730
"Galectins: emerging regulatory checkpoints linking tumor immunity and angiogenesis" (2017) Méndez-Huergo, S.P.; Blidner, A.G.; Rabinovich, G.A. Current Opinion in Immunology. 45:8-15
"In vivo hemin conditioning targets the vascular and immunologic compartments and restrains prostate tumor development" (2017) Jaworski, F.M.;Gentilini, L.D.;Gueron, G. (...)Vazquez, E.S. Clinical Cancer Research. 23(17):5135-5148
"NK cells restrain spontaneous antitumor CD8+ T cell priming through pd-1/pd-l1 interactions with dendritic cells" (2016) Raffo Iraolagoitia, X.L.;Spallanzani, R.G.;Torres, N.I. (...)Fuertes, M.B. Journal of Immunology. 197(3):953-961
"The thyroid hormone triiodothyronine reinvigorates dendritic cells and potentiates anti-tumor immunity" (2016) Alamino, V.A.; Montesinos, M.M.; Rabinovich, G.A.; Pellizas, C.G. OncoImmunology. 5(1)
"Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways" (2016) Rabinovich, G.A.; Conejo-García, J.R. Journal of Molecular Biology. 428(16):3266-3281
"Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways" (2016) Rabinovich, G.A.; Conejo-García, J.R. Journal of Molecular Biology. 428(16):3266-3281
"Vascular galectins: Regulators of tumor progression and targets for cancer therapy" (2013) Thijssen, V.L.; Rabinovich, G.A.; Griffioen, A.W. Cytokine and Growth Factor Reviews. 24(6):547-558
"Glycobiology of immune responses" (2012) Rabinovich, G.A.; van Kooyk, Y.; Cobb, B.A. Annals of the New York Academy of Sciences. 1253(1):1-15
"Oral administration of fluoxetine alters the proliferation/apoptosis balance of lymphoma cells and up-regulates T cell immunity in tumor-bearing mice" (2011) Frick, L.R.;Rapanelli, M.;Arcos, M.L.B. (...)Genaro, A.M. European Journal of Pharmacology. 659(2-3):265-272
"Immunology south of the equator in the Americas" (2008) Rabinovich, G.A.; Kalergis, A.M.; Zwirner, N.W.; Savino, W. Nature Immunology. 9(10):1087-1090
"Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment" (2007) Croci, D.O.;Zacarías Fluck, M.F.;Rico, M.J. (...)Scharovsky, O.G. Cancer Immunology, Immunotherapy. 56(11):1687-1700
"Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells" (2005) Liu, K.;Idoyaga, J.;Charalambous, A. (...)Steinman, R.M. Journal of Experimental Medicine. 202(11):1507-1516
"Dendritic Cells Charged with Apoptotic Tumor Cells Induce Long-Lived Protective CD4+ and CD8+ T Cell Immunity against B16 Melanoma" (2003) Goldszmid, R.S.;Idoyaga, J.;Bravo, A.I. (...)Wainstok, R. Journal of Immunology. 171(11):5940-5947
"Regulation of HLA-DR antigen in monocytes from colorectal cancer patients by in vitro treatment with human recombinant interferon-γ" (2000) Novellino, P.S.;Trejo, Y.G.;Beviacqua, M. (...)Rumi, L.S. Journal of Investigational Allergology and Clinical Immunology. 10(2):90-93
"Effects of sarcoma 180 growth on interleukin-1 and circulating immune complexes" (1994) Chasseing, N.A.; Eugui, E.M.; Borda, E.S.; Rumi, L. Cancer Investigation. 12(4):390-394